The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
I’m Conway Gittens reporting from the New York Stock Exchange. Here’s what we’re watching on TheStreet today. Wall Street ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
2don MSN
The FDA approves a new type of nonopioid painkiller for acute pain. And NBC News speaks to transgender service members who ...
Patriot Ledger on MSN2d
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid ...
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.
On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback